Molecular basis for SOX2-dependent regulation of super-enhancer activity
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Wanki Yoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, Graduate School of Basic Medical Science (GSBMS), Institute for Antimicrobial Resistance Research and Therapeutics,…. Hauptthemen laut MEDLINE: Transcription Factors, Pluripotent Stem Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Pioneer transcription factors (TFs) like SOX2 are vital for stemness and cancer through enhancing gene expression within transcriptional condensates formed with coactivators, RNAs and mediators on super-enhancers (SEs). Despite their importance, how these factors work together for transcriptional condensation and activation remains unclear. SOX2, a pioneer TF found in SEs of pluripotent and cancer stem cells, initiates SE-mediated transcription by binding to nucleosomes, though the mechanism isn’t fully understood. To address SOX2’s role in SEs, we identified mSE078 as a model SOX2-enriched SE and p300 as a coactivator through bioinformatic analysis. In vitro and cell assays showed SOX2 forms condensates with p300 and SOX2-binding motifs in mSE078. We further proved that SOX2 condensation is highly correlated with mSE078’s enhancer activity in cells. Moreover, we successfully demonstrated that p300 not only elevated transcriptional activity but also triggered chromatin acetylation via its direct interaction with SOX2 within these transcriptional condensates. Finally, our validation of SOX2-enriched SEs showcased their contribution to target gene expression in both stem cells and cancer cells. In its entirety, this study imparts valuable mechanistic insights into the collaborative interplay of SOX2 and its coactivator p300, shedding light on the regulation of transcriptional condensation and activation within SOX2-enriched SEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Precision Medicine, Graduate School of Basic Medical Science (GSBMS), Institute for Antimicrobial Resistance Research and Therapeutics, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of…
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
- Department of Mechanical Engineering, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Physics & Astronomy, Seoul National University, Seoul 08826, Republic of Korea.
ORCID-Profile: Wanki Yoo, Jaehoon Kim, Yongdae Shin, Kyeong Kyu Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Yoo, W., Song, Y. W., Kim, J., Ahn, J., Kim, J., Shin, Y., Ryu, J. K., & Kim, K. K. (2023). Molecular basis for SOX2-dependent regulation of super-enhancer activity. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad908
Vancouver
Yoo W, Song YW, Kim J, Ahn J, Kim J, Shin Y, et al. Molecular basis for SOX2-dependent regulation of super-enhancer activity. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad908
BibTeX
@article{Yoo2023,
author = {Yoo, Wanki and Song, Yi Wei and Kim, Jihyun and Ahn, Jihye and Kim, Jaehoon and Shin, Yongdae and Ryu, Je-Kyung and Kim, Kyeong Kyu},
title = {Molecular basis for SOX2-dependent regulation of super-enhancer activity},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad908}
}
EUVIMED